Physician

Haig Tcheurekdjian, M.D.

According to 2025 Medicare claims, Haig Tcheurekdjian, M.D. (NPI: 1992724843) practices allergy/immunology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is ALLERGY IMMUNOLOGY ASSOCIATES INC (NPI: 1922212760; TIN: 34-1151148) and primary practice location at 44124-4034.

Tcheurekdjian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 83,240 HCPCS/CPT codes, and received $4,704,853 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,496 prescription claims across 208 beneficiaries totaling $439,239 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 178 claims. Open Payments data shows 46 records totaling $816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $929,002 to $4,704,853. Similarly, Part D prescription costs have risen steadily, from $115,585 to $439,239. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $628 and ending at $13,308.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	195	33,637	$929,002
2016	261	39,964	$1,170,785
2017	243	43,494	$1,089,054
2018	250	51,760	$1,436,096
2019	247	49,905	$1,489,181
2020	271	59,925	$1,766,218
2021	259	67,401	$2,150,940
2022	238	69,916	$2,855,041
2023	208	81,956	$3,759,795
2024	208	83,240	$4,704,853

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	155	1,004	$115,585
2016	148	920	$104,176
2017	172	1,206	$173,809
2018	169	1,338	$1,242,121
2019	167	1,265	$225,668
2020	205	1,487	$356,937
2021	208	1,527	$489,402
2022	207	1,462	$465,270
2023	212	1,457	$566,216
2024	208	1,496	$439,239

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	15	$362
2016	N/R	42	$2,950
2017	11	100	$14,448
2018	11	83	$13,501
2019	11	115	$54,064
2020	11	184	$114,291
2021	N/R	237	$151,948
2022	N/R	201	$108,828
2023	N/R	97	$59,549
2024	N/R	178	$110,315

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	48	48	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	389	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	39	452	$43
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	38	1,219	$14
96160	Administration and interpretation of patient-focused health risk assessment	52	112	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	23	812	$108,532
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	110	4,020	$84,900
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	1,050	$21,951
Spiriva Respimat	Tiotropium Bromide	32	960	$15,742
Epinephrine	Epinephrine	34	633	$14,380

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	34	$103,571
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	18	$2,081
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,636
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	27	$1,506
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	32	$802

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$816	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Haig Tcheurekdjian, M.D.?

Tedicare shows public-source Medicare data for Haig Tcheurekdjian, M.D. (NPI 1992724843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Haig Tcheurekdjian, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Haig Tcheurekdjian, M.D.?

Haig Tcheurekdjian, M.D. is linked to ALLERGY IMMUNOLOGY ASSOCIATES INC (billing NPI 1922212760) in the available physician profile data.

Does Haig Tcheurekdjian, M.D. have Open Payments data?

Haig Tcheurekdjian, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.